RG7625

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Healthy Volunteer

Phase 1

A Study of RG7625 in Healthy Volunteers

CompletedNCT02295332

Hoffmann-La RocheHealthy Volunteer

Start: 2014-12-31End: 2015-04-30Updated: 2016-11-02

A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers

CompletedNCT02521610

Hoffmann-La RocheHealthy Volunteer

Start: 2015-08-31End: 2015-11-30Updated: 2016-11-02

Related Papers

A randomized, double‐blind, placebo‐controlled, multiple dose, parallel study to investigate the effects of a cathepsin S inhibitor in celiac disease

Clinical and Translational Science2024-12-311 citations

Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S

Frontiers in Immunology2017-07-1742 citations